Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 3 Randomized Study Comparing Talquetamab SC in Combination With Daratumumab SC and Pomalidomide (Tai-DP) or Talquetamab SC in Combination With Daratumumab SC (Tal-D) Versus Daratumumab SC, Pom
Active
$546.3K Funding
4 People
External
Related Topics
clinical trials,
immunotherapy,
multiple myeloma,
combination therapy,
drug development
People
Michele Chu-Pilli
(CD)
Cancer Center Division
﹒Research Program Administration Officer III
Muhammad Husnain
Principal Investigator (PI)
Medicine
﹒Assistant Professor, Medicine - (Clinical Scholar Track)
Francois Chu
(CD)
Cancer Center Division
﹒Research Compliance Administrator I
Ravitharan Krishnadasan
Co-Investigator (COI)
Medicine
﹒Clinical Professor, Medicine - (Clinical Series Track)
